Electromed

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Electromed reports record Q1 revenues, faces CMS waiver expiration

Electromed delivered robust financial performance, driven by strong revenue growth and operational efficiency. The company faces challenges related to potential CMS waiver expiration and CEO succession, but strategic initiatives and market opportunities position it for continued growth. Overall, Electromed's focus on innovation and market expansion bodes well for future success.

Electromed reports record Q2 revenue, focuses on strategic growth

Electromed's Q2 2023 earnings call showcased strong financial performance, particularly in the home care segment. Despite challenges from the expiration of the CMS waiver, the company's strategic growth initiatives and clinical evidence present promising opportunities for future success.

Electromed Inc. reports robust Q3 earnings and targets market expansion

Electromed Inc. delivered strong financial performance in Q3 2023, driven by revenue growth and improved operational efficiency. The company's strategic initiatives and focus on quality assurance position it for continued success. However, managing expenses and balancing revenue across segments will be crucial for sustained growth.

Electromed (ELMD) reports record revenue and eyes growth opportunities

Electromed's Q4 2023 earnings call showcased impressive financial performance, with record revenue and operating income. The company's strategic focus on growth investments, operational excellence, and market development is driving strong results. While facing challenges in optimizing capital deployment, Electromed is well-positioned to leverage opportunities in expanding its market presence and driving further growth.

Electromed (ELMD) achieves record revenue in Q3 2024 earnings call

Electromed (ELMD) delivered robust financial performance in Q3 2024, driven by revenue growth and operational excellence. Despite challenges like a cyberattack and increased expenses, the company remains well-positioned with a strong cash position and growth strategies in place.

Electromed (ELMD) achieves record revenue and market expansion in Q4 2024

Electromed's Q4 2024 performance reflects strong revenue growth, operational excellence, and strategic market initiatives.
While facing challenges in maintaining growth momentum, the company's focus on innovation and market expansion positions it for future success.
With a solid financial position, diverse product portfolio, and growth strategies in place, Electromed is poised for continued growth and market leadership.

Electromed (ELMD) reports robust Q1 earnings and strategic growth plans

Electromed's Q1 2025 performance reflects strong revenue growth, improved profitability, and strategic investments in key areas.
The company's financial stability, operational efficiency, and focus on market expansion position them for sustained success in the medical device industry.
While challenges in maintaining growth persist, Electromed's proactive approach to innovation and market awareness presents opportunities for future expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Electromed, Inc. (NYSE:ELMD ) Q1 2025 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Mike Cavanaugh - IR, Westwicke Partners James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Hello, and welcome to the Electromed First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode.

Electromed, Inc. (ELMD) Q1 2025 Earnings Call Transcript

Aris Water Solution

Defiance Quantum ETF

Revolve

Sezzle Inc

The Stocks Our Experts Are Trading Now

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2024 (“Q1 FY 2025”). Q1 FY 2025 Financial Highlights Net revenue increased 19.0% to $14.7 million in Q1 FY 2025, from $12.3 million in the first quarter of the prior fiscal year. Gross margin was 78.3% of net revenues, compared to 77.1% in the first quarter of the prior fiscal y.

Electromed, Inc. Announces Fiscal 2025 First Quarter Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will release its financial results for the fiscal 2025 first quarter ended September 30, 2024, on November 12, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826.

Electromed, Inc. Schedules its First Quarter Fiscal 2025 Financial Results Conference Call for November 12, 2024 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced the appointment of Peter Horwich as Vice President, Marketing. Mr. Horwich, an accomplished marketing veteran, brings over 20 years of experience in driving commercial growth in the Medical Technology market to Electromed. Prior to joining Electromed, Horwich directed Global Strategic Marketing for Respiratory Therapies at Abiomed (now.

Electromed, Inc., Appoints Peter Horwich, Vice President, Marketing

Shares of Electromed Inc (ELMD, Financial) surged 3.92% in mid-day trading on Oct 2. The stock reached an intraday high of $22.23, before settling at $21.72, up from its previous close of $20.90.

Electromed Inc (ELMD) Trading 3.92% Higher on Oct 2

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that effective as of September 11, 2024, its board of directors authorized the repurchase of up to $5.0 million of Electromed common stock. The new authorization follows the exhaustion of Electromed's previous share repurchase authorization in the fourth quarter of fiscal 2024, as previously reported. The timing and amount of share repu.

Electromed, Inc. Announces Share Repurchase Authorization

Electromed, Inc. (NYSE:ELMD ) Q4 2024 Earnings Conference Call August 27, 2024 5:00 PM ET Company Participants Mike Cavanaugh - IR, Westwicke Partners James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Greetings, and welcome to the Electromed Fourth Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode.

Electromed, Inc. (ELMD) Q4 2024 Earnings Call Transcript

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Fiscal Year 2024 Financial Results.

Electromed, Inc. Announces Record Fiscal Year 2024 Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 fourth quarter ended June 30, 2024, on August 27, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (87.

Electromed, Inc. Schedules its Fourth Quarter Fiscal 2024 Financial Results Conference Call for August 27, 2024 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Canaccord Genuity 44th Annual Global Growth Conference being held in Boston on August 13-15, 2024. Electromed's management team will present at 2:30 p.m. Eastern Time on Wednesday, August 14, 202.

Electromed, Inc. to Participate in the 2024 Canaccord Global Growth Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the 2024 Sidoti June Small-Cap Virtual Conference.

Electromed, Inc. to Participate in the 2024 Sidoti June Small-Cap Virtual Conference

Electromed, Inc. (NYSE:ELMD ) Q3 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Mike Cavanaugh - IR James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Greetings, and welcome to the Electromed Third Quarter Fiscal 2024 Financial Results Conference Call. [Operator Instructions].

Electromed, Inc. (ELMD) Q3 2024 Earnings Call Transcript

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Revenue in Fiscal 2024 Third Quarter.

Electromed, Inc. Announces Record Revenue in Fiscal 2024 Third Quarter

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 third quarter ended March 31, 2024, on May 7, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call b.

Electromed, Inc. Schedules its Third Quarter Fiscal 2024 Financial Results Conference Call for May 7, 2024 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference.

Electromed, Inc. to Participate in the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the 2024 Sidoti March Small-Cap Virtual Conference.

Electromed, Inc. to Participate in the 2024 Sidoti March Small-Cap Virtual Conference

Electromed reported an impressive quarter and expects beneficial results for 2024, with a total market opportunity of 4.2 million Bronchiectasis patients. The company's growth strategies, including direct-to-consumer marketing and internationalization efforts, could drive significant net sales growth. Electromed's stock repurchase program and recent price dynamics make it an attractive investment opportunity.

Electromed: Blowout Quarter, Beneficial 2024 Guidance, And Cheap

Electromed, Inc. (ELMD) Q2 2024 Earnings Call Transcript

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter.

Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Schedules its Second Quarter Fiscal 2024 Financial Results Conference Call for February 13, 2024 at 5:00 p.m. ET.

Electromed, Inc. Schedules its Second Quarter Fiscal 2024 Financial Results Conference Call for February 13, 2024 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Partnership to Expand SmartVest Access to Veterans, Federal Employees, and Native American Communities.

Electromed, Inc. Announces Partnership to Expand SmartVest Access to Veterans, Federal Employees, and Native American Communities

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Virtual 2024 Lytham Partners Investor Select Conference.

Electromed, Inc. to Participate in the Virtual 2024 Lytham Partners Investor Select Conference

Electromed, Inc. (NYSE:ELMD ) Q1 2024 Results Conference Call November 7, 2023 5:00 PM ET Company Participants Mike Cavanaugh - IR, ICR Westwicke Jim Cunniff - President and CEO Brad Nagel - CFO Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Good day, and welcome to the Electromed First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note today's event is being recorded.

Electromed, Inc. (ELMD) Q1 2024 Earnings Call Transcript

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results.

News for Electromed Stock (ELMD)